Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AstraZeneca plc (AZN) vs Baker Hughes Co (BKR) Price & Performance

AstraZeneca plcTrade
Baker Hughes CoTrade

Price performance (Past 24H)

Key statistics

AstraZeneca plc vs Baker Hughes Co — how do they compare? AstraZeneca plc trades at $158.56 (market cap $250.84B), while Baker Hughes Co trades at $64.83 (market cap $63.60B). The key difference: AstraZeneca plc is far larger — about 3.9× Baker Hughes Co's market cap, and AstraZeneca plc pays the higher dividend (1.97%). Which is the better fit depends on your goals.

AZNBKR
Market Cap
$250.84B$63.60B
Sector
HealthEnergy
52-Week High
$209.48$69.67
52-Week Low
$147.06$42.51
Enterprise Value
$278.12B$64.13B
Dividend Yield
1.97%1.44%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About AstraZeneca plc

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.

Read more on AZN

About Baker Hughes Co

Baker Hughes is a global leader in oilfield services and oilfield equipment, with particularly strong presences in the artificial lift, specialty chemicals, and completions markets. The other half of its business focuses on industrial power generation, process solutions, and industrial asset management, with high exposure to the liquid natural gas market specifically, as well as broader industrials end markets.

Read more on BKR